Quince Therapeutics (QNCX) Net Shares Issued and Repurchased (2018 - 2026)

Quince Therapeutics has reported Net Shares Issued and Repurchased for 9 years, with the latest figure at $278293.0 in Q1 2026.

• On a quarterly basis, Net Shares Issued and Repurchased changed N/A year-over-year to $278293.0 in Q1 2026; TTM through Mar 2026 was $278293.0, a N/A change from a year earlier, with the FY2025 full-year figure at $3.3 million, changed N/A from the prior year.
• Net Shares Issued and Repurchased was $278293.0 for Q1 2026 at Quince Therapeutics, down from $3.3 million in the prior quarter.
• The five-year high for Net Shares Issued and Repurchased was $4.2 million in Q4 2022, with the low at $278293.0 in Q1 2026.
• Average Net Shares Issued and Repurchased over 5 years is $2.4 million, with a median of $3.2 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2023: Net Shares Issued and Repurchased soared 762.74% in 2022, then dropped 20.32% in 2023.
• Over 5 years, Net Shares Issued and Repurchased stood at $4.2 million in 2022, then decreased by 20.32% to $3.3 million in 2023, then decreased by 3.14% to $3.2 million in 2024, then rose by 1.4% to $3.3 million in 2025, then plunged by 91.53% to $278293.0 in 2026.
• The last three Net Shares Issued and Repurchased figures came in at $278293.0 (Q1 2026), $3.3 million (Q4 2025), and $3.2 million (Q1 2024), per Business Quant data.